Skip to main content

Toronto Blue Jays starting pitcher Clayton Richard works against the Boston Red Sox during first inning American League MLB baseball action in Toronto on May 23, 2019.

Nathan Denette/The Canadian Press

The injury-depleted Toronto Blue Jays’ rotation got a boost Thursday with the reinstatement of left-hander Clayton Richard from the 10-day injured list.

He was given the starting assignment for a matinee against the Boston Red Sox that will wrap up a four-game series at Rogers Centre.

“He’s going to have 50 to 60 pitches,” Blue Jays manager Charlie Montoyo said before the game. “His last bullpen (session) he looked really good so I’m expecting three or four good innings from him.”

Story continues below advertisement

Starters Ryan Borucki (elbow), Clay Buchholz (shoulder) and Matt Shoemaker (knee) are all on the injured list along with reliever Ryan Tepera (elbow).

Veteran southpaw Ryan Feierabend could be called upon if Montoyo needs some long relief. The knuckleballer worked four innings last Saturday after his contract was selected from triple-A Buffalo.

Richard made only one minor-league start before getting the nod against the Red Sox. He was acquired from San Diego last December but started the season on the IL due to a right knee injury.

The 35-year-old left-hander was 7-11 with a 5.33 earned-run average last season over 27 starts with the Padres last year.

The Toronto bullpen has also been taxed of late, with five relievers playing in a 6-5, 13-inning loss to the Red Sox on Wednesday night.

“That’s one thing I’ve learned from experience is you can never have enough pitching,” Montoyo said. “Nobody expected three or four guys to get hurt. So it is what it is.

“We’ve just got to deal with it until we get healthy again.”

Story continues below advertisement

To make room on the 25-man roster, the Blue Jays optioned right-hander Jimmy Cordero to Buffalo

He shouldered the loss Wednesday after giving up a solo homer to Michael Chavis in the 13th inning.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter